Basic Information
ID: ALA781737
Type: Functional
Description: Subcutaneous dose giving half-maximal decrease of Dopa formation in the rat brain (limbic)
Format: BAO_0000221
Tissue: Brain
Target: Dopamine receptor(ALA2093868)
Document: ALA1122750
Subcutaneous dose giving half-maximal decrease of Dopa formation in the rat brain (limbic): 1
Activity Charts
Bioactivity
Activity Types for Assay ALA781737
ED50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 247.38 | 3.37 | 3.37 |
| 247.38 | 3.37 | 3.37 |
| 247.38 | 3.37 | 3.37 |
| 300.24 | 2.64 | 2.64 |
| 356.35 | 4.20 | 4.20 |
| 286.21 | 2.25 | 2.25 |
| 300.24 | 2.59 | 2.59 |
| 272.19 | 1.81 | 1.81 |
| 286.21 | 2.25 | 2.25 |
| 272.19 | 1.86 | 1.86 |
| 258.16 | 1.47 | 1.47 |
| 314.27 | 2.98 | 2.98 |
| 376.34 | 4.16 | 4.16 |
| 312.25 | 2.74 | 2.74 |
| 356.35 | 4.15 | 4.15 |
| 342.32 | 3.76 | 3.76 |
| 297.87 | 3.67 | 3.67 |